Psyence and Filament Health Announce Worldwide Licensing Agreement of Psilocybin Capsule for Palliative Care Read more
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat, a Novel Non-Purine Xanthine Oxidase Inhibitor for the Treatment of Gout Disease Read more
Harrow Enters into Agreement to Acquire Exclusive U.S. Rights to ILEVRO, NEVANAC, VIGAMOX, MAXIDEX, and TRIESENCE Read more
Biosion Announces Research Collaboration with ImmunoGen to Create Novel Antibody-Drug Conjugates Read more
European Commission approves SPEVIGO (spesolimab) for generalized pustular psoriasis flares Read more